Sumati Gupta, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    QED
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bristol Myers Squibb
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Incyte
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Rexahn
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    LSK
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Acrotech
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Astra Zeneca
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Clovis
    Date added:
    09/20/2022
    Date updated:
    09/20/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Date added:
    09/20/2022
    Date updated:
    09/20/2022

Pages

Return to 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes